Fortrea Holdings (FTRE) Other Non-Current Liabilities (2022 - 2026)

Fortrea Holdings (FTRE) reported Other Non-Current Liabilities of $37.8 million for Q1 2026, up 4.13% on a YoY basis from $36.3 million in Q1 2025, and down 3.82% quarter-over-quarter from $39.3 million in Q4 2025.

Fortrea Holdings (FTRE) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Other Non-Current Liabilities for 5 years, with the latest figure at $37.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities rose 4.13% year-over-year to $37.8 million; the trailing twelve-month figure through Mar 2026 stood at $37.8 million (up 4.13% YoY), and the FY2025 full-year result was $39.3 million, up 11.33% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $37.8 million, down from $39.3 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $39.3 million in Q4 2025, with the low at $21.7 million in Q4 2022.
  • Historically, Other Non-Current Liabilities has averaged $34.2 million across 5 years, with a median of $36.3 million in 2025.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities soared 47.93% — and 2024, when it declined 20.0%.
  • Fortrea Holdings' Other Non-Current Liabilities stood at $21.7 million in 2022, then soared by 47.93% to $32.1 million in 2023, then gained by 9.97% to $35.3 million in 2024, then gained by 11.33% to $39.3 million in 2025, then dropped by 3.82% to $37.8 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $37.8 million (Q1 2026), $39.3 million (Q4 2025), and $36.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 37.80 Mn
Dec 31, 2025 39.30 Mn
Sep 30, 2025 36.40 Mn
Jun 30, 2025 37.00 Mn
Mar 31, 2025 36.30 Mn
Dec 31, 2024 35.30 Mn
Sep 30, 2024 37.60 Mn
Jun 30, 2024 29.60 Mn
Mar 31, 2024 28.90 Mn
Dec 31, 2023 32.10 Mn
Sep 30, 2023 35.70 Mn
Jun 30, 2023 37.00 Mn
Dec 31, 2022 21.70 Mn